Market Overview

JNJ Spokesperson Says, 'Our team put a temporarily hold on enrollment so we could assess the enrolled currently patients against the protocol criteria. We need to make sure we don't over-enroll some patient types and under-enroll others.'

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News FDA Exclusives

 

Related Articles (JNJ + TSRO)